Dr Rosemary Balleine

On this page

Grants | Publications

Current national competitive grants*

2007

Breast Cancer Tissue Bank
Clarke C, Baxter R, Bilous M, Boyages J, Carpenter J, Forbes J, Friedlander M, Harnett P, Kefford R, Marsh D, Morey A, Scott R, Spigelman A, Sutherland R, Balleine R
National Breast Cancer Foundation Project Grants ($1,455,090 over 5 years)

* Grants administered through the University of Sydney

Publications

2009

Graham, J., Mote, P., Salagame, U., van Dijk, J., Balleine, R., Huschtscha, L., Reddel, R., Clarke, C. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology. 2009; 150:3318-3326. [Abstract]

2008

Balleine, R., Webster, L., Davis, S., Salisbury, E., Palazzo, J., Schwartz, G., Cornfield, D., Walker, R., Byth, K., Clarke, C., Meltzer, P. Molecular Grading of Ductal Carcinoma In situ of the Breast. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008; 14:8244-8252. [Abstract]

Scurr, L., Guminski, A., Chiew, Y., Balleine, R., Sharma, R., Lei, Y., Pryor, K., Wain, G., Brand, A., Byth, K., Kennedy, C., Rizos, H., Harnett, P., Defazio, A. Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer. Clinical Cancer Research. 2008; 14:6924-6932. [Abstract]

Webster, L., Lee, S., Ringland, C., Morey, A., Hanby, A., Morgan, G., Byth, K., Mote, P., Provan, P., Ellis, I., Green, A., Lamoury, G., Ravdin, P., Clarke, C., Ward, R., Balleine, R., Hawkins, N. Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification. Clinical Cancer Research. 2008; 14:6625-6633. [Abstract]

Loughrey, M., Provan, P., Byth, K., Balleine, R., kConFab, I. Histopathological features of ''BRCAX'' familial breast cancers in the kConFab resource. Pathology. 2008; 40:352-358. [Abstract]

2007

Gurney, H., Wong, M., Balleine, R., Rivory, L., McLachlan, A., Hoskins, J., Wilcken, N., Clarke, C., Mann, G., Collins, M., Delforce, S., Lynch, K., Schran, H. Imatinib Disposition and ABCB1 (MDR1, P-Glycoprotein) Genotype. Clinical pharmacology and therapeutics. 2007; 82:33-40. [Abstract]

2006

Farshid, G., Balleine, R., Cummings, M., Waring, P., , T. Morphology of Breast Cancer as a Means of Triage of Patients for BRCA1 Genetic Testing. The American journal of surgical pathology. 2006; 30:1357-1366. [Abstract]

Balleine, R., Murali, R., Bilous, A., Farshid, G., Waring, P., Provan, P., Byth, K., Thorne, H., , K., Kirk, J. Histopathological features of breast cancer in carriers of ATM gene variants. Histopathology. 2006; 49:523-32. [Abstract]

Wong, M., Balleine, R., Blair, E., McLachlan, A., Ackland, S., Garg, M., Evans, S., Farlow, D., Collins, M., Rivory, L., Hoskins, J., Mann, G., Clarke, C., Gurney, H. Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006; 24:2448-55. [Abstract]

Guminski, A., Balleine, R., Chiew, Y., Webster, L., Tapner, M., Farrell, G., Harnett, P., Defazio, A. MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma. Gynecologic oncology. 2006; 100:239-46. [Abstract]

Mann, G., Thorne, H., Balleine, R., Butow, P., Clarke, C., Edkins, E., Evans, G., Fereday, S., Haan, E., Gattas, M., Giles, G., Goldblatt, J., Hopper, J., Kirk, J., Leary, J., Lindeman, G., Niedermayr, E., Phillips, K., Picken, S., Pupo, G., Saunders, C., Scott, C., Spurdle, A., Suthers, G., Tucker, K., Chenevix-Trench, G., , K. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast cancer research : BCR. 2006; 8:R12. [Abstract]

2005

Byrne, J., Balleine, R., Fejzo, M., Mercieca, J., Chiew, Y., Livnat, Y., St Heaps, L., Peters, G., Byth, K., Karlan, B., Slamon, D., Harnett, P., Defazio, A. Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer. International journal of cancer. Journal international du cancer. 2005; 117:1049-54. [Abstract]

Webster, L., Bilous, A., Willis, L., Byth, K., Burgemeister, F., Salisbury, E., Clarke, C., Balleine, R. Histopathologic indicators of breast cancer biology: insights from population mammographic screening. British journal of cancer. 2005; 92:1366-71. [Abstract]

Wong, M., Evans, S., Rivory, L., Hoskins, J., Mann, G., Farlow, D., Clarke, C., Balleine, R., Gurney, H. Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer. Clinical pharmacology and therapeutics. 2005; 77:33-42. [Abstract]

2004

Wong, M., Balleine, R., Collins, M., Liddle, C., Clarke, C., Gurney, H. CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy. Clinical pharmacology and therapeutics. 2004; 75:529-38. [Abstract]

Balleine, R., Earls, P., Webster, L., Mote, P., deFazio, A., Harnett, P., Clarke, C. Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 2004; 23:138-44. [Abstract]

2002

Balleine, R., Kefford, R. Targeting molecular mechanisms in cancer. ANZ journal of surgery. 2002; 72:760-3. [Abstract]

2001

Balleine, R., Humphrey, K., Clarke, C. Tumour banks: providing human tissue for cancer research. Medical Journal of Australia. 2001; 41:320-325.

2000

Mote, P., Balleine, R., Mcgowan, E., Clarke, C. Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma. Human Reproduction. 2000; 15:48-56.

Balleine, R., Schoenberg Fejzo, M., Sathasivam, P., Basset, P., Clarke, C., Byrne, J. The hD52 (TDP52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma. Genes, Chromosomes & Cancer. 2000; 29:48-57.

[Show all 20 publications][Hide publications]